Table 3.
ESBL-PE carriage at admission and during ICU stay*
| At admission, n (%) | ICU acquired, n (%) | Total, n (%) | |
|---|---|---|---|
| Escherichia coli | 10 (52.6) | 9 (47.4) | 19 (100) |
| Klebsiella pneumoniae | 11 (16.2) | 57 (83.8) | 68 (100) |
| Enterobacter cloacae | 5 (18.5) | 22 (81.5) | 27 (100) |
| Serratia marcescens | 1 (16.7) | 5 (83.3) | 6 (100) |
| Enterobacter aerogenes | 0 | 3 (100) | 3 (100) |
| Enterobacter asburiae | 1 (50) | 1 (50) | 2 (100) |
| Citrobacter freundii | 0 | 1 (100) | 1 (100) |
| Klebsiella oxytoca | 0 | 1 (100) | 1 (100) |
| Total | 28 (22) | 99 (78) | 127 (100) |
ESBL-PE = extended-spectrum beta-lactamase–producing Enterobacteriaceae; ICU = intensive care unit. Six patients were carrying two ESBL-PE (one at admission and five during ICU stay).
*
Only the first ESBL-PE carriage in each patient was reported.